Herpes Zoster Vaccine Update
Shingrix (GSK), the herpes zoster subunit vaccine (a two-shot series), was approved by the FDA in Fall 2018 and is currently approved for use in adults 50 years and older.
News
RheumNow Podcast –Favorites of ACR 2019 (11.22.19)
Dr. Jack Cush recaps standout presentations and information from ACR 2019 held in Atlanta November 9-12, 2019.
A Focus on WOCBA (Women of Childbearing Age)
Largely because it can be difficult to do studies in pregnant women, gaps remain in the area of rheumatic disease in pregnancy. This year’s ACR highlights some important new points to consider.
ACR 2019 - Report From Day 3 (Tuesday)
Here's my summary of key studies presented Tuesday.
Tofacitinib in Polyarticular JIA
Psoriatic Arthritis at ACR 2019
Below are several of the highlight studies in psoriatic arthritis (PsA) presented at the ACR 2019 annual meeting in Atlanta.
Muscle Loss and Frailty in Rheumatic Disease
At the 2019 ACR annual meeting, several abstracts looked at the importance of myopia (muscle wasting due to illness at any age) and sarcopenia (age related muscle wasting) in the setting of various rheumatologic diseases.
ACR 2019 - Report From Day 2 (Monday)
Monday was another full day of sessions and studies here in Atlanta. Following is my roundup of day two.
The Safety of Methotrexate
Influenza Vaccine Updates And Pearls At ACR 2019
As we enter flu season it is of the utmost importance that we remember to assess our patients’ influenza vaccine status at each visit.
PANLAR Ultrasound Study Group: Recommendations On Imaging Modalities In Gout
Gout is a systemic inflammatory disease with high potential for joint damage due to erosive changes and MSU deposits resulting in disability and chronic pain. Prompt diagnosis and effective treatment are key to better long term outcomes and decreased disability.
ACR 2019 – Best of the Plenary Sessions
The ACR Plenary Sessions featured some of the best research presented on Sunday, Monday, and Tuesday in Atlanta. Here are my seven notable highlights from the Plenaries.
Hepatitis C-Related Cryoglobulinemic Vasculitis
Flares of vasculitis can still be a problem after hepatitis C-related cryoglobulinemic vasculitis patients are cured of their hepatitis C by direct-acting antivirals, as demonstrated by data from four registries presented at ACR 2019 in Atlanta, Georgia.
ACR 2019 - Report from Day One (Sunday)
Sunday was the first full day of scientific sessions at the 2019 ACR/ARP meeting in Atlanta. Yesterday we shared our initial news articles, videos and more with you. Following is my roundup of day one.
Delays in Diagnosis
